INDIRECT COST BURDEN FOR INDIVIDUALS LIVING WITH SICKLE CELL DISEASE WITH RECURRENT VASOOCCLUSIVE CRISES IN EUROPE

被引:0
|
作者
Lilly, L. [1 ]
Drahos, J. [1 ]
Boateng-Kuffour, A. [1 ]
Calvert, M. [2 ]
Valentine, A. [3 ]
Mason, A. [4 ]
Li, N. [1 ]
Pakbaz, Z. [5 ]
Shah, F. [6 ]
Ainsworth, N. [7 ]
Udeze, C. [1 ]
Martin, A. [7 ]
机构
[1] Vertex Pharmaceut Inc, Boston, MA USA
[2] Univ Birmingham, Birmingham, England
[3] Sick Cells, Washington, DC USA
[4] Sickle Cell Care Manchester, Manchester, England
[5] Univ Calif Irvine, Sch Med, Orange, CA USA
[6] NHS Blood & Transplant, London, England
[7] QC Med, Liverpool, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
EE262
引用
收藏
页码:S101 / S102
页数:2
相关论文
共 50 条
  • [11] VASOOCCLUSIVE CRISIS EPISODES IN SICKLE-CELL DISEASE
    ADHIKARY, PK
    HARA, S
    DWIVEDI, C
    DAVIS, JW
    WEAVER, C
    PAVULURI, SR
    JOURNAL OF MEDICINE, 1986, 17 (3-4) : 227 - 240
  • [12] Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
    Udeze, Chuka
    Evans, Kristin A.
    Yang, Yoojung
    Lillehaugen, Timothy
    Manjelievskaia, Janna
    Mujumdar, Urvi
    Li, Nanxin
    Andemariam, Biree
    ADVANCES IN THERAPY, 2023, 40 (08) : 3543 - 3558
  • [13] Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
    Chuka Udeze
    Kristin A. Evans
    Yoojung Yang
    Timothy Lillehaugen
    Janna Manjelievskaia
    Urvi Mujumdar
    Nanxin Li
    Biree Andemariam
    Advances in Therapy, 2023, 40 : 3543 - 3558
  • [14] Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels
    Al Huneini, M.
    Alkindi, S.
    Panjwani, V.
    Al Falahi, K.
    Al Balushi, B.
    Gravell, D.
    Ho, C. H.
    Krishnamoorthy, R.
    Pathare, A. V.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
  • [15] Crises in Sickle Cell Disease
    Novelli, Enrico M.
    Gladwin, Mark T.
    CHEST, 2016, 149 (04) : 1082 - 1093
  • [16] Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
    Chuka Udeze
    Kristin A. Evans
    Yoojung Yang
    Timothy Lillehaugen
    Janna Manjelievskaia
    Urvi Mujumdar
    Nanxin Li
    Biree Andemariam
    Advances in Therapy, 2023, 40 : 5130 - 5130
  • [17] ROLE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS FOR THE TREATMENT OF VASOOCCLUSIVE CRISES OF SICKLE-CELL-ANEMIA
    BILECKOT, R
    SEMAINE DES HOPITAUX, 1993, 69 (19): : 584 - 587
  • [18] CT of Gastrointestinal Vasoocclusive Crisis Complicating Sickle Cell Disease
    Gardner, Carly S.
    Jaffe, Tracy A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 204 (05) : 994 - 999
  • [19] USE OF KETOROLAC IN SICKLE-CELL DISEASE AND VASOOCCLUSIVE CRISIS
    GOODMAN, E
    LANCET, 1991, 338 (8767): : 641 - 642
  • [20] EFFECT OF INTRAVENOUS UREA IN CONTROL OF PAIN FROM VASOOCCLUSIVE CRISES IN SICKLE-CELL ANEMIA
    JILLY, PN
    UY, CG
    HUDSON, RL
    SCOTT, RB
    BULLOCK, WH
    PEDIATRIC RESEARCH, 1974, 8 (04) : 402 - 402